Skin biopsy study aims to unlock Vitiligo's repigmentation mystery
NCT ID NCT06068218
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares skin samples from 20 people with vitiligo and 20 healthy volunteers to understand why certain body areas (like the face) repigment well while others (like hands and feet) do not. Researchers will analyze gene activity in skin from five different body sites. The goal is to identify factors that help or hinder repigmentation, which could guide future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal why certain body areas repigment better, pointing toward more targeted treatments for vitiligo.
- What could go wrong
- This is a small, observational study with only 20 participants. It aims to understand biology, not test a treatment, so direct patient benefits are far off.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice - Hôpital de l'Archet
Nice, Alpes-maritimes, 06200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data unlock better skin disease care?
- New ointment aims to restore skin color in vitiligo
- Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
- New vitiligo registry aims to uncover disease trends in 2,500 patients
- Scientists probe immune secrets of four skin diseases
- Lamp vs laser: which light works best for vitiligo?